Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Measurable Residual Disease (MRD)”

222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 222 results

Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Large-scale testing (Phase 3)Looking for participantsNCT03793517
What this trial is testing

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Who this might be right for
Stem Cell Transplant ComplicationsLeukemia, Myeloid, AcuteLeukemia Relapse
Peking University People's Hospital 55
Very early researchNot Yet RecruitingNCT06979661
What this trial is testing

Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy

Who this might be right for
Lung CancerNon Small Cell Lung CancerLung Cancer Recurrent
Rutgers, The State University of New Jersey 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03863184
What this trial is testing

Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL

Who this might be right for
Mantle Cell Lymphoma
Weill Medical College of Cornell University 37
Early research (Phase 1)Looking for participantsNCT05535855
What this trial is testing

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1

Who this might be right for
Acute Lymphoid LeukemiaAcute Lymphoblastic Leukemia
University of Colorado, Denver 29
Testing effectiveness (Phase 2)Ended earlyNCT01158885
What this trial is testing

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Who this might be right for
Minimal Residual DiseaseLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute
Therapeutic Advances in Childhood Leukemia Consortium 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07301138
What this trial is testing

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Ruijin Hospital 23
Testing effectiveness (Phase 2)UnknownNCT04689815
What this trial is testing

Oral Arsenic Trioxide for NPM1-mutated AML

Who this might be right for
NPMc+ AML
The University of Hong Kong 50
Not applicableUnknownNCT05426850
What this trial is testing

CtDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 100
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Not applicableNot Yet RecruitingNCT06449846
What this trial is testing

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma ResectableSurgeryRecurrence
Zhujiang Hospital 152
Not applicableUnknownNCT02872662
What this trial is testing

Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT

Who this might be right for
MDSSCTMRD
Nordic MDS Group 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05182385
What this trial is testing

Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

Who this might be right for
ALL, Recurrent, Adult
Goethe University 30
Not applicableLooking for participantsNCT07104058
What this trial is testing

A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

Who this might be right for
IgG4-Related Diseases
Luo Yaping 46
Testing effectiveness (Phase 2)Looking for participantsNCT06974786
What this trial is testing

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC 100
Not applicableNot Yet RecruitingNCT07382505
What this trial is testing

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Who this might be right for
Uterine NeoplasmsCervical Cancer
Asan Medical Center 600
Testing effectiveness (Phase 2)Study completedNCT00458523
What this trial is testing

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission

Who this might be right for
Leukemia
Leeds Cancer Centre at St. James's University Hospital 54
Not applicableNot Yet RecruitingNCT06287723
What this trial is testing

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

Who this might be right for
Colorectal CancerLiver MetastasesStage IV Colorectal Cancer+3 more
University Hospital, Montpellier 30
Not applicableStudy completedNCT02010931
What this trial is testing

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 310
Load More Results